Blue Jet Healthcare Ltd: Fundamental Analysis, Share Price Insights & Intrinsic Value (2024)

Share Price and Basic Stock Data

Last Updated: December 23, 2024, 10:20 am

Market Cap	9,835 Cr.
Current Price	567
High / Low	603/324
Stock P/E	56.3
Book Value	53.3
Dividend Yield	0.18 %
ROCE	30.0 %
ROE	22.4 %
Face Value	2.00
PEG Ratio	-16.09

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Blue Jet Healthcare Ltd

Competitors of

Stock Name	Market Cap	Current Price	High / Low	Stock P/E	Book Value	Dividend Yield	ROCE	ROE	Face Value
Blue Jet Healthcare Ltd	9,835 Cr.	567	603/324	56.3	53.3	0.18 %	30.0 %	22.4 %	2.00
Industry Average	9,835.00 Cr	567.00		56.30	53.30	0.18%	30.00%	22.40%	2.00

All Competitor Stocks of

Quarterly Result

Month	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Sales	145	190	169	217	180	181	167	184	163	208
Expenses	106	132	117	147	121	119	112	131	119	139
Operating Profit	38	59	52	70	59	63	55	53	44	69
OPM %	27%	31%	31%	32%	33%	35%	33%	29%	27%	33%
Other Income	4	7	6	6	5	8	-3	9	9	12
Interest	0	0	0	0	0	0	0	0	0	0
Depreciation	6	6	7	6	6	6	8	8	3	5
Profit before tax	36	59	51	70	58	64	44	54	49	77
Tax %	24%	26%	27%	27%	24%	26%	27%	27%	24%	24%
Net Profit	28	44	38	51	44	48	32	40	38	58
EPS in Rs	1.61	2.53	2.16	2.92	2.54	2.76	1.85	2.29	2.18	3.36

Last Updated: November 6, 2024, 7:08 pm

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: October 23, 2024, 2:56 pm

Month	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	538	499	683	721	712	695
Expenses	325	292	434	502	482	480
Operating Profit	214	207	249	219	229	215
OPM %	40%	41%	36%	30%	32%	31%
Other Income	6	9	19	24	19	23
Interest	7	5	3	1	0	0
Depreciation	18	20	22	25	28	26
Profit before tax	194	190	243	217	220	212
Tax %	25%	26%	25%	26%	26%
Net Profit	145	142	182	160	164	157
EPS in Rs	24,118.33	1,428.57	10.47	9.23	9.44	9.08
Dividend Payout %	0%	0%	0%	0%	11%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	-2.07%	28.17%	-12.09%	2.50%
Change in YoY Net Profit Growth (%)	0.00%	30.24%	-40.26%	14.59%

Blue Jet Healthcare Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 4 years from 2020-2021 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	%
5 Years:	%
3 Years:	13%
TTM:	-3%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	7%
TTM:	-3%

Stock Price CAGR
10 Years:	%
5 Years:	%
3 Years:	%
1 Year:	56%

Return on Equity
10 Years:	%
5 Years:	%
3 Years:	28%
Last Year:	22%

Last Updated: Unknown

Balance Sheet

Last Updated: December 14, 2024, 2:04 pm

Month	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	0.60	10	35	35	35	35
Reserves	198	330	487	647	811	889
Borrowings	74	53	19	5	3	1
Other Liabilities	92	143	173	176	211	256
Total Liabilities	364	536	713	862	1,059	1,181
Fixed Assets	107	-0	156	151	172	268
CWIP	2	3	3	30	147	85
Investments	26	37	94	189	250	293
Other Assets	229	497	460	491	489	535
Total Assets	364	536	713	862	1,059	1,181

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	122	137	146	142	241
Cash from Investing Activity +	-45	-61	-76	-147	-264
Cash from Financing Activity +	-72	-21	-56	-4	-2
Net Cash Flow	5	55	14	-10	-24

Free Cash Flow

Month	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	140.00	154.00	230.00	214.00	226.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	80	105	121	121	91
Inventory Days	120	201	133	137	151
Days Payable	90	101	72	58	35
Cash Conversion Cycle	110	204	183	199	206
Working Capital Days	64	105	105	121	93
ROCE %		58%	52%	35%	30%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Promoters	86.00%	86.00%	86.00%	86.00%
FIIs	2.93%	2.01%	2.02%	2.18%
DIIs	3.70%	3.04%	2.14%	1.75%
Public	7.37%	8.97%	9.83%	10.06%
No. of Shareholders	55,589	48,625	42,882	41,933

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund	1,080,413	1.01	37.17	367,344	2024-12-22	194.11%
ICICI Prudential Innovation Fund	732,067	0.6	25.18	367,344	2024-12-22	99.29%
HDFC Business Cycle Fund	367,344	0.43	12.64	367,344	2024-12-22	0%
Bandhan Small Cap Fund	285,391	0.22	9.82	367,344	2024-12-22	-22.31%
Edelweiss Recently Listed IPO Fund	231,403	0.84	7.96	367,344	2024-12-22	-37.01%
Edelweiss Aggressive Hybrid Fund	144,480	0.37	4.97	367,344	2024-12-22	-60.67%
Edelweiss Aggressive Hybrid Fund - Plan B	144,480	0.37	4.97	367,344	2024-12-22	-60.67%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 21	Mar 20
FaceValue	100.00	100.00
Basic EPS (Rs.)	1396.27	1462.59
Diluted EPS (Rs.)	1396.27	1462.59
Cash EPS (Rs.)	1568.30	27166.33
Book Value[Excl.RevalReserv]/Share (Rs.)	3428.34	32238.33
Book Value[Incl.RevalReserv]/Share (Rs.)	3428.34	32238.33
Revenue From Operations / Share (Rs.)	5033.61	89699.16
PBDIT / Share (Rs.)	2168.43	36589.16
PBIT / Share (Rs.)	1970.05	33582.66
PBT / Share (Rs.)	1862.96	32354.50
Net Profit / Share (Rs.)	1369.92	24159.83
NP After MI And SOA / Share (Rs.)	1396.43	24141.33
PBDIT Margin (%)	43.07	40.79
PBIT Margin (%)	39.13	37.43
PBT Margin (%)	37.01	36.07
Net Profit Margin (%)	27.21	26.93
NP After MI And SOA Margin (%)	27.74	26.91
Return on Networth / Equity (%)	40.73	75.40
Return on Capital Employeed (%)	52.32	83.21
Return On Assets (%)	25.94	38.58
Long Term Debt / Equity (X)	0.08	0.19
Total Debt / Equity (X)	0.10	0.30
Asset Turnover Ratio (%)	1.10	0.00
Current Ratio (X)	2.43	1.89
Quick Ratio (X)	1.69	1.37
Inventory Turnover Ratio (X)	2.30	0.00
Interest Coverage Ratio (X)	40.49	29.79
Interest Coverage Ratio (Post Tax) (X)	27.58	20.67

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Blue Jet Healthcare Ltd as of December 23, 2024 is: 673.39

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of December 23, 2024, Blue Jet Healthcare Ltd is Undervalued by 18.76% compared to the current share price 567.00

Intrinsic Value of Blue Jet Healthcare Ltd as of December 23, 2024 is: 649.83

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of December 23, 2024, Blue Jet Healthcare Ltd is Undervalued by 14.61% compared to the current share price 567.00

Last 5 Year EPS CAGR: -3.50%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock is trading at a low valuation with an average P/B ratio of 17,776.36 and average Dividend Yield of 38.28%. The stock has a high average ROCE of 35.00%, which is a positive sign. The company has higher reserves (560.33 cr) compared to borrowings (25.83 cr), indicating strong financial stability. The company has shown consistent growth in sales (641.33 cr) and profit (212.67 cr) over the years.	The stock has a high average Working Capital Days of 97.60, which may not be favorable. The stock has a high average Cash Conversion Cycle of 180.40, which may not be favorable.

Strength

Weakness

The stock is trading at a low valuation with an average P/B ratio of 17,776.36 and average Dividend Yield of 38.28%.
The stock has a high average ROCE of 35.00%, which is a positive sign.
The company has higher reserves (560.33 cr) compared to borrowings (25.83 cr), indicating strong financial stability.
The company has shown consistent growth in sales (641.33 cr) and profit (212.67 cr) over the years.

The stock has a high average Working Capital Days of 97.60, which may not be favorable.
The stock has a high average Cash Conversion Cycle of 180.40, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Blue Jet Healthcare Ltd:
1. Net Profit Margin: 27.21%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 52.32% (Industry Average ROCE: 30%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 40.73% (Industry Average ROE: 22.4%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 27.58
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 1.69
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 56.3 (Industry average Stock P/E: 56.3)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.1
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Pharmaceuticals

INDUSTRY	ADDRESS	CONTACT
701, 702, 7th Floor, Navi Mumbai Maharashtra 400705	Mr.	Akshay%20Bansarilal%20Arora Executive%20Chairman

Management
Name	Position Held
Mr. Shiven Akshay Arora	Managing Director
Mr. Naresh Suryakant Shah	Executive Director
Ms. Divya Sameer Momaya	Independent Director
Mr. Girish Paman Vanvari	Independent Director
Ms. Preeti Gautam Mehta	Independent Director

FAQ

What is the latest intrinsic value of ?

The latest intrinsic value of as on 23 December 2024 is ₹673.39, which is 18.76% higher than the current market price of ₹567.00. The stock has a market capitalization of 9,835 Cr. and recorded a high/low of 603/324 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹889 Cr and total liabilities of ₹1,181 Cr.

What is the Market Cap of ?

The Market Cap of is 9,835 Cr..

What is the current Stock Price of as on 23 December 2024?

The current stock price of as on 23 December 2024 is 567.

What is the High / Low of stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of stocks is 603/324.

What is the Stock P/E of ?

The Stock P/E of is 56.3.

What is the Book Value of ?

The Book Value of is 53.3.

What is the Dividend Yield of ?

The Dividend Yield of is 0.18 %.

What is the ROCE of ?

The ROCE of is 30.0 %.

What is the ROE of ?

The ROE of is 22.4 %.

What is the Face Value of ?

The Face Value of is 2.00.